Based on the proteomics results and a preliminary CRISPR screen, the authors designed a dual knockout CRISPR library where they could target 119 proteins containing strong KRAS interactors and proteins suspected to be involved in KRAS transformation of lung cancer cells. The gene discussed is KRAS; the disease is lung carcinoma.